Guangfei Ou

1.4k total citations · 1 hit paper
20 papers, 1.2k citations indexed

About

Guangfei Ou is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Guangfei Ou has authored 20 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pulmonary and Respiratory Medicine, 6 papers in Cancer Research and 5 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Guangfei Ou's work include Lung Cancer Diagnosis and Treatment (6 papers), Cancer, Hypoxia, and Metabolism (4 papers) and Lung Cancer Treatments and Mutations (4 papers). Guangfei Ou is often cited by papers focused on Lung Cancer Diagnosis and Treatment (6 papers), Cancer, Hypoxia, and Metabolism (4 papers) and Lung Cancer Treatments and Mutations (4 papers). Guangfei Ou collaborates with scholars based in China, Japan and United States. Guangfei Ou's co-authors include Hiroshi Harada, Satoshi Itasaka, Masahiro Hiraoka, Akiyo Morinibu, Kazumi Shinomiya, Michio Yoshimura, Kiichi Hirota, Ruth J. Muschel, W. Gillies McKenna and Lihua Zeng and has published in prestigious journals such as Nature Communications, Clinical Cancer Research and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Guangfei Ou

19 papers receiving 1.2k citations

Hit Papers

Correction: Corrigendum: Cancer cells that survive radiat... 2013 2026 2017 2021 2013 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Correction: Corrigendum: Cancer cells that survive radiation therapy acquire HIF-1 activity and translocate toward tumour blood vessels
    2013 621 citations Hiroshi Harada, Masahiro Inoue et al. Nature Communications profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Guangfei Ou China 12 262 253 191 179 173 20 1.2k
Kazumi Shinomiya Japan 12 522 2.0× 104 0.4× 536 2.8× 181 1.0× 180 1.0× 12 1.4k
Akiyo Morinibu Japan 16 615 2.3× 121 0.5× 612 3.2× 219 1.2× 203 1.2× 19 1.5k
Daisuke Shimizu Japan 26 313 1.2× 291 1.2× 168 0.9× 287 1.6× 48 0.3× 167 2.0k
Guo‐Ming Zhang China 16 219 0.8× 90 0.4× 103 0.5× 79 0.4× 150 0.9× 59 1.3k
Yoshihiro Morita Japan 23 534 2.0× 153 0.6× 143 0.7× 276 1.5× 298 1.7× 95 1.7k
Xudong Zhang China 28 456 1.7× 195 0.8× 278 1.5× 252 1.4× 417 2.4× 111 2.4k
Yoshiaki Yamada Japan 31 418 1.6× 252 1.0× 66 0.3× 166 0.9× 130 0.8× 199 3.1k
Paul A. Reynolds United Kingdom 24 849 3.2× 158 0.6× 204 1.1× 260 1.5× 211 1.2× 59 1.7k
Jeroen Goos Netherlands 16 390 1.5× 114 0.5× 119 0.6× 173 1.0× 415 2.4× 32 1.8k
Shangfeng Liu China 23 817 3.1× 80 0.3× 186 1.0× 236 1.3× 151 0.9× 107 1.8k

Countries citing papers authored by Guangfei Ou

Since Specialization
Citations

This map shows the geographic impact of Guangfei Ou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guangfei Ou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guangfei Ou more than expected).

Fields of papers citing papers by Guangfei Ou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guangfei Ou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guangfei Ou. The network helps show where Guangfei Ou may publish in the future.

Co-authorship network of co-authors of Guangfei Ou

This figure shows the co-authorship network connecting the top 25 collaborators of Guangfei Ou. A scholar is included among the top collaborators of Guangfei Ou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guangfei Ou. Guangfei Ou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Yongqing, Shiji Zhao, Abdus Salam, et al.. (2025). Laccase-Responsive Biobased Nanocarriers from Lignin/Chitosan for Enhanced Foliar Adhesion and Targeted Pesticide Delivery. ACS Sustainable Chemistry & Engineering. 13(42). 18188–18201. 1 indexed citations
2.
3.
Wu, Long, et al.. (2025). Fatty acid-binding proteins in cancers. International Journal of Surgery. 111(11). 8402–8422. 3 indexed citations
4.
5.
Zhang, Ya, et al.. (2025). Prognostic impact of primary versus secondary resistance to sorafenib in patients with HCC. Therapeutic Advances in Medical Oncology. 17. 12744414–12744414. 2 indexed citations
6.
Qu, Baolin, Woo Sik Yu, Yan Huang, et al.. (2015). Radiotherapy effects on brain/bone metastatic adenocarcinoma lung cancer and the importance of EGFR mutation test. Neoplasma. 63(1). 158–162. 5 indexed citations
7.
Harada, Hiroshi, Masahiro Inoue, Satoshi Itasaka, et al.. (2013). Correction: Corrigendum: Cancer cells that survive radiation therapy acquire HIF-1 activity and translocate toward tumour blood vessels. Nature Communications. 4(1). 621 indexed citations breakdown →
8.
9.
Zhao, Lujun, Guangfei Ou, Jima Lv, et al.. (2012). Risk factors for radiation-induced lung toxicity in patients with non-small cell lung cancer who received postoperative radiation therapy. Lung Cancer. 77(2). 326–330. 15 indexed citations
10.
Harada, Hiroshi, Masahiro Inoue, Satoshi Itasaka, et al.. (2012). Cancer cells that survive radiation therapy acquire HIF-1 activity and translocate towards tumour blood vessels. Nature Communications. 3(1). 783–783. 154 indexed citations
11.
Dai, Honghai, Zhouguang Hui, Wei Ji, et al.. (2011). Postoperative Radiotherapy for Resected Pathological Stage IIIA–N2 Non-Small Cell Lung Cancer: A Retrospective Study of 221 Cases from a Single Institution. The Oncologist. 16(5). 641–650. 65 indexed citations
12.
Zhao, Lujun, Wei Ji, Li Zhang, et al.. (2010). Changes of Circulating Transforming Growth Factor-²1 Level During Radiation Therapy Are Correlated with the Prognosis of Locally Advanced Non-small Cell Lung Cancer. Journal of Thoracic Oncology. 5(4). 521–525. 29 indexed citations
13.
Chen, Yidong, Qinfu Feng, Haizhen Lu, et al.. (2010). Role of Adjuvant Radiotherapy for Stage II Thymoma After Complete Tumor Resection. International Journal of Radiation Oncology*Biology*Physics. 78(5). 1400–1406. 45 indexed citations
14.
Bi, Nan, Ming Yang, Li Zhang, et al.. (2010). Cyclooxygenase-2 Genetic Variants Are Associated with Survival in Unresectable Locally Advanced Non–Small Cell Lung Cancer. Clinical Cancer Research. 16(8). 2383–2390. 37 indexed citations
15.
Ou, Guangfei, Satoshi Itasaka, Lihua Zeng, et al.. (2009). Usefulness of HIF-1 Imaging for Determining Optimal Timing of Combining Bevacizumab and Radiotherapy. International Journal of Radiation Oncology*Biology*Physics. 75(2). 463–467. 17 indexed citations
16.
Zeng, Lihua, Guangfei Ou, Satoshi Itasaka, et al.. (2008). TS‐1 enhances the effect of radiotherapy by suppressing radiation‐induced hypoxia‐inducible factor‐1 activation and inducing endothelial cell apoptosis. Cancer Science. 99(11). 2327–2335. 43 indexed citations
17.
Zhu, Xixu, et al.. (2006). 2461. International Journal of Radiation Oncology*Biology*Physics. 66(3). S466–S466. 1 indexed citations
18.
Li, Jun, Zhaochen Shan, Guangfei Ou, et al.. (2005). Structural and functional characteristics of irradiation damage to parotid glands in the miniature pig. International Journal of Radiation Oncology*Biology*Physics. 62(5). 1510–1516. 53 indexed citations
19.
Wang, Yingjie, Lvhua Wang, Qinfu Feng, et al.. (2005). [Factors predicting radiation toxicity in the treatment of three-dimensional conformal radiotherapy for lung cancer].. PubMed. 8(5). 454–8. 2 indexed citations
20.
Qin, De‐Xing, Guangfei Ou, Hao Mo, et al.. (2001). Improved efficacy of chemotherapy for glioblastoma by radiation-induced opening of blood-brain barrier: clinical results. International Journal of Radiation Oncology*Biology*Physics. 51(4). 959–962. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kazumi Shinomiya Breakdown of academic impact, for papers by Akiyo Morinibu Breakdown of academic impact, for papers by Daisuke Shimizu Breakdown of academic impact, for papers by Guo‐Ming Zhang Breakdown of academic impact, for papers by Yoshihiro Morita Breakdown of academic impact, for papers by Xudong Zhang Breakdown of academic impact, for papers by Yoshiaki Yamada Breakdown of academic impact, for papers by Paul A. Reynolds Breakdown of academic impact, for papers by Jeroen Goos Breakdown of academic impact, for papers by Shangfeng Liu
Rankless by CCL
2026